


| Key | % Net Assets |
|---|---|
| 4.5% | |
| 3.8% | |
| 3.5% | |
| 3.5% | |
| 84.7% |
| Name | % Net Assets |
|---|---|
| Sanofi-Aventis | 4.5% |
| Credit Suisse | 3.8% |
| Novartis | 3.5% |
| Total | 3.5% |
| Roche | 3.3% |
| Unilever | 3.3% |
| Siemens | 3.2% |
| Banco Santander | 3.2% |
| Anheuser-Busch | 2.9% |
| Zurich Financial Services | 2.8% |
No asset data available.
| Date | 19-Aug-2025 |
|---|---|
| NAV | 1,097.70p |
| Currency | GBP |
| Change | 8.71p |
| % | 0.80% |
| YTD change | 127.20p |
| YTD % | 13.11% |
| Fund Inception | 27/08/1986 |
|---|---|
| Fund Manager | Aaron Barnfather / Mark Little and team |
| TER | 1.07 (31-Mar-2014) |
| Minimum Investment | |
|---|---|
| Initial | £200000 |
| Additional | £500 |
| Savings | £75 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.06 |
You are here: research